.Christopher & Dana Reeve Foundation’s CSO Marco Baptista and Lineage Cell Therapeutics’s Brian Culley kick off Day 1 of #SCISymposium. Stay tuned for updates throughout the conference! See here for more: scisymposium.com California Institute for Regenerative Medicine #SCI #SpinalCordInjury

Great insights learned from the Preclinical #SpinalCordInjury Session, moderated by Baird’s Jack Allen and Adrien Cohen, SCI Ventures, featuring Inteligex, NeuroHagana, Novoron Bioscience, SaniaRx, ReWire Medical, and Axonis Therapeutics, Inc.. Lineage Cell Therapeutics California Institute for Regenerative Medicine Christopher & Dana Reeve Foundation #SCI

Thanks for a fantastic Day 1 of the #SCISymposium. We look forward to learning more and continuing the great discussions tomorrow! See the agenda here: bit.ly/4clRXqf Lineage Cell Therapeutics Christopher & Dana Reeve Foundation California Institute for Regenerative Medicine #SCI #SpinalCordInjury

Today we kick off Day 2 of #SCISymposium with California Institute for Regenerative Medicine’s Lila Collins, Ph.D., and Lineage Cell Therapeutics’s Brian Culley. Stay tuned for updates throughout the conference! See here for more: bit.ly/3mzDtOX Christopher & Dana Reeve Foundation #SCI #SpinalCordInjury

Jerod Nieder, Hanna Nieder, Michaela Devins, and Kyle Devins spoke about their lived experiences with #SpinalCordInjury in an engaging discussion with Joseph Pantginis, Ph.D. of H.C. Wainwright & Co.. Lineage Cell Therapeutics California Institute for Regenerative Medicine Christopher & Dana Reeve Foundation #SCI

Exciting updates presented from @Neuralink, Lineage Cell Therapeutics, @AbbVie, ONWARD Medical, nerv 01, & Kringle Pharma during the Clinical #SCI session, moderated by Joseph Pantginis, Ph.D. of H.C. Wainwright & Co. Learn more: scisymposium.com Christopher & Dana Reeve Foundation California Institute for Regenerative Medicine #CollaboratetoInnovate

An insightful session from Tari Suprapto, Ph.D., of Novo Nordisk, Ilan Zipkin, Ph.D., of Supercede Therapeutics & Breakout Ventures, and moderator Liz Meeks of Leerink Partners on the investors’ perspective on #SCI. Lineage Cell Therapeutics Christopher & Dana Reeve Foundation California Institute for Regenerative Medicine #CollaboratetoInnovate

And that’s a wrap! Thanks so much to all the attendees, sponsors, and presenters, who made #SCISymposium a great success! Keep an eye out for more information on replays from the Symposium in the coming weeks! #SCI #SpinalCordInjury Lineage Cell Therapeutics Christopher & Dana Reeve Foundation California Institute for Regenerative Medicine

🙏 Thanks to Lineage Cell Therapeutics and our strategic partner, the Christopher & Dana Reeve Foundation for hosting the 2nd Annual SCI Symposium, which aims to boost investment in breakthrough therapies for those with spinal cord injury (SCI). Our own VP Communications,

Missed the 2024 @SCISymposium? Watch California Institute for Regenerative Medicine' Lila R. Collins, Ph.D., discuss their focus on advancing regenerative medicine and spinal cord injury therapies. bit.ly/3XP4BsY Explore all 2024 Symposium presentations: bit.ly/4gGdQDo #SCI #SCIResearch

Watch a powerful panel discussion on living with #SCI from our @SCISymposium, moderated by Joseph Pantginis, PhD, H.C. Wainwright & Co.. Hosted by Lineage Cell Therapeutics @CIRMNews Christopher & Dana Reeve Foundation. bit.ly/3XZDrjl #SpinalCordInjury

📅 Save the date! The 3rd Annual Spinal Cord Injury Investor Symposium returns as a virtual event on June 27, 2025, presented by Lineage Cell Therapeutics and Christopher & Dana Reeve Foundation. Join us! For more: bit.ly/4jdJHvU @SCIsymposium @CIRMNews #SCI #SpinalCordInjury

.Lineage Cell Therapeutics & Christopher & Dana Reeve Foundation are excited to announce registration for the 3rd Annual @SCIsymposium. Presenters: @NervGenP NurExone Biologic (TSXV: NRX) (Germany: J90) ONWARD Medical H.C. Wainwright & Co. Precision Neuroscience @RUSHMedical @RWBaird @Umiamimedicine Robert Paylor Kessler Foundation Shirley Ryan AbilityLab bit.ly/3mzDtOX

Registration is open for the 3rd Annual SCI Investor Symposium. Investors now have an opportunity to connect directly with the teams which are driving innovation and next-generation therapies in SCI. Register and request your 1-on-1 meetings with participating companies today:

.Lineage Cell Therapeutics and Christopher & Dana Reeve Foundation are excited to announce the initial agenda for the 3rd Annual @SCISymposium! scisymposium.com/2025-agenda/ Presenters are still being added. Reminder to investors to register and request your 1-on-1 meetings with participating companies today:

.Lineage Cell Therapeutics and Christopher & Dana Reeve Foundation are excited to announce @Paradromics and Synchron as additional presenters for the 3rd Annual @SCISymposium! scisymposium.com/2025-agenda/ Presenters also include Lineage Cell Therapeutics, @NervGenP, ONWARD Medical, Precision Neuroscience, Spiderwort Biotechnologies Inc.,

We are 3 days away from the SCI Investor Symposium hosted by Lineage Cell Therapeutics and Christopher & Dana Reeve Foundation Investors can register and request their 1-on-1 meetings with participating companies: bit.ly/4e7UbeE Presenters include Lineage Cell Therapeutics, @NervGenP, NurExone Biologic (TSXV: NRX) (Germany: J90), ONWARD Medical,

The @SCISymposium kicks off tomorrow — don’t miss your chance to listen to leading companies advancing spinal cord injury research. bit.ly/3mzDtOX Presenters include Lineage Cell Therapeutics, @NervGenP, NurExone Biologic (TSXV: NRX) (Germany: J90), ONWARD Medical, @Paradromics, Spiderwort Biotechnologies Inc., Synchron,

The @SCISymposium is happening now — discover how innovators are driving progress in spinal cord injury treatment. bit.ly/3mzDtOX Presenters include Lineage Cell Therapeutics, @NervGenP, NurExone Biologic (TSXV: NRX) (Germany: J90), ONWARD Medical, @Paradromics, Spiderwort Biotechnologies Inc., Synchron, @RUSHMedical,

#ICYMI: The @SCISymposium brought together a powerful lineup of companies and researchers advancing spinal cord injury treatment. Event replays are now available: bit.ly/3mzDtOX Thank you to all who joined us: Lineage Cell Therapeutics, @NervGenP, NurExone Biologic (TSXV: NRX) (Germany: J90), ONWARD Medical,